September 15, 2022: We are writing to express our views on the Consumer Product Safety Commission’s adoption of a mandatory safety standard for infant sling carriers. We enthusiastically support the plan to make the current CPSC voluntary safety standards – which address product test methods, performance requirements, labeling and instructional literature –mandatory for manufacturers in […]
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
NCHR Comments on the CMS National Coverage Analysis of Seat Extenders for Wheelchairs
September 14, 2022: We strongly support the coverage of wheelchair seat extender systems through Medicare and encourage CMS quickly act on this decision. There are numerous direct medical benefits from the use of power seat elevation systems in power wheelchairs. Many preventable complications and secondary conditions are common among individuals who spend long periods of time unable to stand or walk, restricted to a bed, chair, or wheelchair.
Read More »NCHR Public Comment on Genital Herpes Screening
September 12, 2022: We are writing to express our views on the USPSTF updates to its recommendations regarding asymptomatic serum screening for genital herpes (HSV-2). The National Center for Health Research (NCHR) is a nonprofit think tank that conducts, analyzes, and scrutinizes research on a range of health issues, with particular focus on which prevention […]
Read More »NCHR Comments on the Calendar Year 2023 Medicare Physician Fee Schedule
September 8, 2022: We are encouraged to see policies in this Proposed Rule that would increase access to quality healthcare for millions of vulnerable Americans. NCHR supports the proposal for continued expansion of coverage for telemental health services. We also support the provision to cover substance use disorder (SUD) for Medicare beneficiaries.
Read More »NCHR Comments on the Office of Dietary Supplements (ODS) Proposed Draft of Their Strategic Plan (2022-2026)
August 31, 2022: NCHR supports the efforts to improve research in the ODS proposed strategic plan but recommends several revisions, primarily focusing on the “Addressing Health Disparities and Advancing Health Equity”.
Read More »